MtROS-induced NADPH oxidase activation could be also prevented by inhibitors of the mPTP, PKC, tyrosine kinase cSrc, NADPH oxidases and be amplified by mitochondrial superoxide dismutase deficiency, which led to endothelial dysfunction in angiotensin II-induced hypertension [44]. The gene discussed is FMO5; the disease is Hypertension.